Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP261883.RA9R6ZY0phuXdK3rTP_94md_ElCH4_VDT--rz1AAT1hwM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP261883.RA9R6ZY0phuXdK3rTP_94md_ElCH4_VDT--rz1AAT1hwM130_assertion type Assertion NP261883.RA9R6ZY0phuXdK3rTP_94md_ElCH4_VDT--rz1AAT1hwM130_head.
- NP261883.RA9R6ZY0phuXdK3rTP_94md_ElCH4_VDT--rz1AAT1hwM130_assertion description "[Further, after plumbagin treatment, activated AMPK directly phosphorylates Raptor to inhibit mTOR complex 1 (mTORC1) activation and Bcl-2 expression in colon cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261883.RA9R6ZY0phuXdK3rTP_94md_ElCH4_VDT--rz1AAT1hwM130_provenance.
- NP261883.RA9R6ZY0phuXdK3rTP_94md_ElCH4_VDT--rz1AAT1hwM130_assertion evidence source_evidence_literature NP261883.RA9R6ZY0phuXdK3rTP_94md_ElCH4_VDT--rz1AAT1hwM130_provenance.
- NP261883.RA9R6ZY0phuXdK3rTP_94md_ElCH4_VDT--rz1AAT1hwM130_assertion SIO_000772 23712032 NP261883.RA9R6ZY0phuXdK3rTP_94md_ElCH4_VDT--rz1AAT1hwM130_provenance.
- NP261883.RA9R6ZY0phuXdK3rTP_94md_ElCH4_VDT--rz1AAT1hwM130_assertion wasDerivedFrom befree-20150227 NP261883.RA9R6ZY0phuXdK3rTP_94md_ElCH4_VDT--rz1AAT1hwM130_provenance.
- NP261883.RA9R6ZY0phuXdK3rTP_94md_ElCH4_VDT--rz1AAT1hwM130_assertion wasGeneratedBy ECO_0000203 NP261883.RA9R6ZY0phuXdK3rTP_94md_ElCH4_VDT--rz1AAT1hwM130_provenance.